CRP and atherosclerosis: A definitive way to test this concept would be the use of novel drugs that specifically block CRP binding and its proinflammatory effects in vivo,[28] which can be a powerful tool for determining whether increased CRP production merely reflects atherosclerosis or does indeed participate in its pathogenesis and complications, and they could also have cardioprotective effects in depressed patients.